Ascend Advanced Therapies
London, United Kingdom
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (1)
○ MHRA GMP
Quick Facts: Ascend Advanced Therapies
- Signal Score
- 78.1/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- London, United Kingdom
- Modalities
- AAV, Lentiviral, Plasmid
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Ascend Advanced Therapies
Spun out of former Spark Therapeutics manufacturing team.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA InspectionsNo US records on file
EMA GMP Certificates1 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
58.0
Profile-based capacity assessment
Ascend Advanced Therapies EMA GMP Compliance 1 certificates
2024-09
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BY_04_GMP_2025_0088 | Ascend Advanced Therapies GmbH | Germany | 2024-09-19 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 07, 2026
Frequently Asked Questions About Ascend Advanced Therapies
Does Ascend Advanced Therapies hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 EMA GMP certificate for Ascend Advanced Therapies.
What is Ascend Advanced Therapies's CDMO Signal Score?
Ascend Advanced Therapies has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Ascend Advanced Therapies for a manufacturing program?
Use the free AI matchmaker to compare Ascend Advanced Therapies against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 81.0
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid
uBriGene Biosciences
Shanghai, CN · Boston, MA
Signal Score: 56.5
AAV, Lentiviral, Plasmid